Trauma and Stressor Related Disorders

Disorders in which exposure to a traumatic or stressful event is explicitly a diagnostic criterion.

Also Known As:

Trauma and Stress Related Disorders

Networked: 19 relevant articles (2 outcomes, 3 trials/studies)

Relationship Network

Disease Context: Research Results

Mental Disorders: 24177
- Trauma and Stressor Related Disorders: 19

Related Diseases

1.	Anxiety Disorders (Anxiety Disorder)
2.	Neoplasms (Cancer)
3.	Conversion Disorder (Astasia Abasia)
4.	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
5.	Wounds and Injuries (Trauma)

Experts

1.	Gunduz-Cinar, Ozge: 2 articles (01/2021 - 05/2016)
2.	Arai, Tetsuaki: 1 article (09/2022)
3.	Asada, Takashi: 1 article (09/2022)
4.	Ishida, Ikki: 1 article (09/2022)
5.	Kunugi, Hiroshi: 1 article (09/2022)
6.	Nemoto, Kiyotaka: 1 article (09/2022)
7.	Ota, Miho: 1 article (09/2022)
8.	Sato, Shinji: 1 article (09/2022)
9.	Brown, Richard J: 1 article (01/2022)
10.	Terhune, Devin B: 1 article (01/2022)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Trauma and Stressor Related Disorders:

1.	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/01/2020 - "The authors identified 14 articles reporting on well-designed clinical trials investigating the efficacy of lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and ayahuasca for the treatment of mood and anxiety disorders, trauma and stress-related disorders, and substance-related and addictive disorders as well as in end-of-life care. "
2.	Psilocybin (Psilocibin)IBA 01/01/2020 - "The authors identified 14 articles reporting on well-designed clinical trials investigating the efficacy of lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and ayahuasca for the treatment of mood and anxiety disorders, trauma and stress-related disorders, and substance-related and addictive disorders as well as in end-of-life care. "
3.	Lysergic Acid Diethylamide (LSD)IBA 01/01/2020 - "The authors identified 14 articles reporting on well-designed clinical trials investigating the efficacy of lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and ayahuasca for the treatment of mood and anxiety disorders, trauma and stress-related disorders, and substance-related and addictive disorders as well as in end-of-life care. "
4.	Hypnotics and Sedatives (Sedatives)IBA 01/01/2022 - "This study assessed whether patients with DDs, trauma- and stressor-related disorders (TSDs), and functional neurological disorder (FND) display elevated hypnotic suggestibility. "
5.	EndocannabinoidsIBA 01/01/2021 - "Involvement of the endocannabinoids in fear extinction makes the endocannabinoid system very attractive for finding effective therapeutics for trauma and stress related disorders. "
6.	AdiponectinIBA 01/01/2020 - "Peripheral adiponectin levels in anxiety, mood, trauma- and stressor-related disorders: A systematic review and meta-analysis." 01/01/2020 - "Peripheral adiponectin levels appear to be inversely associated with anxiety, mood, trauma- and stressor related disorders and may be a promising biomarker for diagnosis and disease monitoring."
7.	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/01/2023 - "Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment for a variety of anxiety-, trauma- and stressor-related disorders. "
8.	Biomarkers (Surrogate Marker)IBA 01/01/2020 - "Peripheral adiponectin levels appear to be inversely associated with anxiety, mood, trauma- and stressor related disorders and may be a promising biomarker for diagnosis and disease monitoring."
9.	4- Acetamido- 4'- isothiocyanatostilbene- 2,2'- disulfonic Acid (SITS)IBA 01/01/2015 - "Posttraumatic stress disorder (PTSD) now sits within the newly created "Trauma- and Stressor-Related Disorders" section of the Diagnostic and Statistical Manual of Mental Disorders (fifth edition; DSM-5). "
10.	Gonadal Steroid Hormones (Sex Hormones)IBA 01/01/2015 - "As anxiety, trauma- and stressor-related disorders are more common in women, recent research focuses on female sex hormones and identifies a potential role for estradiol in fear extinction. "

Therapies and Procedures

1.	Terminal Care (Care, Terminal) 01/01/2020 - "The authors identified 14 articles reporting on well-designed clinical trials investigating the efficacy of lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), psilocybin, and ayahuasca for the treatment of mood and anxiety disorders, trauma and stress-related disorders, and substance-related and addictive disorders as well as in end-of-life care. "
2.	Therapeutics 12/27/2022 - "Exposure-based therapy is an effective first-line treatment for anxiety-, obsessive-compulsive, and trauma- and stressor-related disorders; however, many patients do not improve, resulting in prolonged suffering and poorly used resources. " 01/01/2021 - "Most providers reported primarily offering TMH services to adults with anxiety, depression, and trauma-and stressor-related disorders in individual therapy formats. " 01/01/2019 - "Symptoms of trauma and stressor related disorders such as post-traumatic stress disorder (PTSD) often develop well after the traumatic experience has occurred, and so identifying early predictors of risk or resilience is important for the implementation of interventional therapies. " 01/01/2015 - "The present research developed mindfulness and metta-based trauma therapy (MMTT) as an internet resource to support the practice of mindfulness and metta (lovingkindness) meditations for self-regulation and healing from trauma and stressor-related disorders. " 01/01/2021 - "Involvement of the endocannabinoids in fear extinction makes the endocannabinoid system very attractive for finding effective therapeutics for trauma and stress related disorders. "
3.	Stem Cell Transplantation 09/02/2019 - "Trauma- and stressor-related disorders among hematological cancer patients with and without stem cell transplantation: protocol of an interview-based study according to updated diagnostic criteria."
4.	Drug Therapy (Chemotherapy) 05/01/2016 - "Taken together, these findings reveal a novel, obligatory role for amygdala eCBs in the proextinction effects of a major pharmacotherapy for trauma- and stressor-related disorders and anxiety disorders. "